Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Apple launches Watch-powered atrial fibrillation study

The firm's Apple Heart Study app will see it collaborate with Stanford Medicine

Apple Watch

Apple is collaborating with Stanford Medicine on a study that uses the tech firm’s smartwatch to monitor for atrial fibrillation.

The first-of-its-kind project will see the Apple Watch’s heart rate sensor used to collect heart data, with participants found to have an irregular rhythm offered a free consultation with a study doctor and an electrocardiogram (ECG) patch for additional monitoring.

Jeff Williams, Apple’s COO, said: “Every week we receive incredible customer letters about how Apple Watch has affected their lives, including learning that they have AFib. These stories inspire us and we're determined to do more to help people understand their health.

“Working alongside the medical community, not only can we inform people of certain health conditions, we also hope to advance discoveries in heart science.”

The Apple Heart Study app is available in the US App Store to adults who have an Apple Watch Series 1 or later and who are aged 22 or older.

Meanwhile, Apple is reportedly working on more advanced heart-monitoring features for future versions of the smartwatch that could see it incorporate EKG functionality.

9th January 2018

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Graphite

Graphite is a digital agency which partners with globally respected pharma and healthcare organisations to create powerful digital experiences. We...

Latest intelligence

Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...
Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...